EmpaCHD: Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease (clinicaltrials.gov) - Sep 18, 2026 - P4 | N=40 | Active, not recruiting | Sponsor: Anita Saraf | Recruiting ➔ Active, not recruiting
Enrollment closed • Cardiovascular • Congestive Heart Failure • Heart Failure
|